| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |